Jiangsu Hengrui Medicine
600276.SS
#489
Rank
ยฃ33.32 B
Marketcap
ยฃ5.22
Share price
-1.55%
Change (1 day)
1.20%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): ยฃ0.07546

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is ยฃ0.07200. In 2022 the company made an earnings per share (EPS) of ยฃ0.07179 a decrease over its 2021 EPS that were of ยฃ0.08660.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.075465.11%
2022ยฃ0.07179-17.1%
2021ยฃ0.08660-24.44%
2020ยฃ0.1120.3%
2019ยฃ0.0952725.58%
2018ยฃ0.0758627.55%
2017ยฃ0.0594821.64%
2016ยฃ0.0489013.57%
2015ยฃ0.0430539.86%
2014ยฃ0.0307821.33%
2013ยฃ0.0253717.7%
2012ยฃ0.0215625.56%
2011ยฃ0.0171726.22%
2010ยฃ0.0136010.3%
2009ยฃ0.0123357.92%
2008ยฃ0.00780811.06%
2007ยฃ0.00703185.81%
2006ยฃ0.00378487.94%
2005ยฃ0.00201333.97%
2004ยฃ0.00150329.78%
2003ยฃ0.00115819.78%
2002ยฃ0.0009666